These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 733603)

  • 1. [MOPP chemotherapy of generalized Hodgkin's disease].
    Zieliński T; Krajewska B; Solska E; Karnicka-Młodkowska H
    Nowotwory; 1978 Dec; 28(4):453-9. PubMed ID: 733603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 4. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
    Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of Hodgkin's disease.
    Desforges JF; Rutherford CJ
    Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA; Madej G; Piemkowska F
    Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M; Lauria F; Mazza P; Tura S
    Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
    Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
    Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 18. Prednisone in MOPP chemotherapy for Hodgkin's disease.
    Jacobs C; Portlock CS; Rosenberg SA
    Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease therapeutic program.
    DeVita VT
    JAMA; 1972 Nov; 222(9):1171. PubMed ID: 4678060
    [No Abstract]   [Full Text] [Related]  

  • 20. The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
    Andrieu JM; Bayle-Weisgerber C; Boiron M; Briere JF; Clot P; Dana M; Jacquillat C; Katz M; Teillet F
    Eur J Cancer (1965); 1979 Feb; 15(2):153-61. PubMed ID: 374084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.